The Biotech Growth Trust PLC (LON:BIOG – Get Free Report) insider Julie Tankard acquired 1,022 shares of the stock in a transaction on Wednesday, December 4th. The stock was acquired at an average cost of GBX 972 ($12.40) per share, for a total transaction of £9,933.84 ($12,675.56).
The Biotech Growth Trust Price Performance
BIOG stock opened at GBX 940 ($11.99) on Friday. The firm has a 50 day moving average of GBX 998.20 and a 200-day moving average of GBX 999.03. The Biotech Growth Trust PLC has a 12-month low of GBX 761 ($9.71) and a 12-month high of GBX 1,068.36 ($13.63). The company has a current ratio of 0.33, a quick ratio of 0.00 and a debt-to-equity ratio of 13.03. The company has a market cap of £302.02 million, a price-to-earnings ratio of 454.11 and a beta of 0.50.
The Biotech Growth Trust Company Profile
Recommended Stories
- Five stocks we like better than The Biotech Growth Trust
- Trading Halts Explained
- NVIDIA’s Blackwell Chips Set for Arizona Manufacturing by TSMC?
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- Okta: Bullish Signals Suggest a Market Reversal Is Underway
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- BlackRock Makes Waves With $12B Private Credit Acquisition
Receive News & Ratings for The Biotech Growth Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Biotech Growth Trust and related companies with MarketBeat.com's FREE daily email newsletter.